The apo E gene located on chromosome 19 in humans is polymorphic. The three apo E isoforms E2, E3, and E4 are coded by three common alleles of the gene. The amyloid plaques in brains of Alzheimer disease (AD) patients are known to contain apo E. There is an increased prevalence of E4 allele in AD patients, apo E exhibits increased binding to a peptide AI3 deriving from amylold precursor protein, apo E, the risk factor for late AD d~sease is unable to prevent formation of paired helical filaments which in turn destabilizes neuronal microtubules.
INTRODUCTION
Apolipoproteln E (apo E) has a major role in lipid metabolism (1). This 34 kilodalton (kd) protein is coded by a single four exon gene, 3.6 kilo base (Kb) apo E also plays a neurological role.
Indeed, in addition, to the liver, the brain is also a major source of apo E. Synthesis of apo E occurs primarily in the astrocytes (2). The presence of apoE in the cerebrospinal fluid in contrast to the absence of both LDL and apo B points to a major role for apo E in the transport of lipids in the central nervous system. The dramatic increase in apo E levels after peripheral nerve injury is a prelude to its regeneration.
As a consequence of injury to the nerve, cellular debris is created from axon degeneration and myelin destruction, apo E scavenges cholesterol from the debris and at first delivers it to the macrophages that have been recruited to the site of damage. As the regeneration of nerve begins apo E delivers cholesterol to sprouting neurites which have acquired at their tip LDL receptors for the uptake of cholesterol that is required for membrane synthesis, apo E also provides cholesterol to Schwann cells via LDL receptors on these cells. Thus the process of remyelinization of the regenerated axon by Schwann cells is facilitated by apo E.
The ability of apo E to bind heparin and heparin-like gtycosaminoglycans that constitute the matrix of the arterial wall suggests a role for it in smooth muscle cell proliferation and differentiation (1).
The fact that apo E containing lipoproteins and LDL can interact with specific sites on the surface of lymphocytes suggests also a role for apo E in immunomodulation (1).
Structure of apo E
The secondary structure of apo E has a predominance of c~-helix (62 %). The remainder 
apo E Polymorphism

Association of E4 Allele and Alzheimer's Disease (AD)
Increase in E4 allele number reduces the age of onset of AD. In one study 42 families with late onset of AD was examined (5). The fact that 91% of subjects with genotype E4/4 and 47% of subjects with genotypes E2/4 or E3/4
were affected indicates the importance of the E4 allele in late-onset AD. In contrast only 20% of subjects with one copy of E2 and one of E3
(genotype E2/3) or genotype E3/3 were affected.
The mean age of onset of AD with no E4 allele was 84.3 (standard error of the mean SEM 1.3), and 75.5 (SEM 1.0) with 1 E4 allele.
However, the mean age of onset of AD 
E4 and the Pathogenesis of AD
In subjects with E4 allele, extra cellular neuritic plaques representing deposits of amyloid beta (A&) peptide were noted to be more extensive (6). Subjects with two E4 alleles at autopsies show increased beta amyloid staining compared with other AD subjects. (7).
Subjects with E2 allele, however, had less extensive deposition of A& peptide.
Experiments conducted in vitro have demonstrated that apoE4 and AI'$ peptide interact readily to form a very stable complex (8).
In contrast apoE3 interacts less readily with AI~ peptLde in vitro.
The extensive net work of monofibrils formed between Ar~-peptide and apoE4 in vitro, This interaction takes place possibly through association with apoE or other ligands for the receptors (6). The apoE 4 isoform may be defective in cleanng &A4 from the neuropil due to e~ther altered apoE-&A4 interactions or due to lower levels of apoE (6).
Early-Onset Alzheimer's Disease
Mutations in three genes have been 
